Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Topical Rambazole (0.35% R115866 gel) for mild to moderate facial acne vulgaris
2005-004448-30Phase 2Active
- Sponsor
- Barrier Therapeutics, Inc.
- Start
- Dec 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in acne vulgaris comparing Rambazole 0.35% gel with Vehicle gel (placebo) (2 arms). Started Dec 2005; status: active.
02
Drugs
talarozole
03
Conditions
acne vulgaris
Beyond the preview
Go deeper on 2005-004448-30.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-004448-30.